Condensed Consolidated Statements of Operations and Comprehensive Income and Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Product revenue	$ 24,994	$ 19,784
Cost of goods sold	(3,736)	(2,845)
Gross profit	21,258	16,939
Operating expenses:
Research and development expenses	9,824	5,007
Selling, general and administrative expenses	13,071	11,290
Total operating expenses	22,895	16,297
Operating (loss) income	(1,637)	642
Interest income	787	618
Other (expense) income	(58)	4
(Loss) income before income taxes	(908)	1,264
Income tax expense	162	195
Net (loss) income	(1,070)	1,069
Other comprehensive income (loss):
Unrealized gain on investments adjustments	45	239
Foreign currency translation adjustments	(49)	60
Total comprehensive (loss) income	$ (1,074)	$ 1,368
Common share data:
Basic (loss) income per common share (in dollars per share)	$ (0.03)	$ 0.03
Weighted average number of basic shares outstanding (in shares)	36,021,210	34,642,641
Diluted (loss) income per common share (in dollars per share)	$ (0.03)	$ 0.03
Weighted average number of diluted shares outstanding (in shares)	36,021,210	39,511,120